Filing Details
- Accession Number:
- 0000899243-21-031104
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-02 20:12:23
- Reporting Period:
- 2021-07-29
- Accepted Time:
- 2021-08-02 20:12:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1841387 | Candel Therapeutics Inc. | CADL | Biological Products, (No Disgnostic Substances) (2836) | 522214851 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1873465 | Christopher Martell | C/O Candel Therapeutics, Inc. 117 Kendrick St., Suite 450 Needham MA 02494 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-07-29 | 283,514 | $0.00 | 283,514 | No | 4 | C | Indirect | By GTAM1 2012 ADV LLC |
| Common Stock | Acquisiton | 2021-07-29 | 125,000 | $8.00 | 125,000 | No | 4 | P | Indirect | By GTAM1 2012 LLC |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Indirect | By GTAM1 2012 ADV LLC |
| No | 4 | P | Indirect | By GTAM1 2012 LLC |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series B Preferred Stock | Disposition | 2021-07-29 | 696,851 | $0.00 | 283,514 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Indirect |
Footnotes
- These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date.
- Shares held by GTAM1 2012 ADV LLC, for which the Reporting Person serves as manager. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any.
- Shares held by GTAM1 2012 LLC, which is wholly owned by a trust for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any.
Billionaire Hedge Funds
